skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Found 689 results for your search:
Relevant funding data is only available when one cancer type or one research topic is selected.
Fiscal Year FY 2011
Cancer Type [Hodgkins disease, Non Hodgkins Lymphoma]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 689 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount Principal
Investigator
Institution
1
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA 5R01CA101700-07 $343,695 GLICKSON, JERRY UNIVERSITY OF PENNSYLVANIA
2
1st International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymp 1R13CA159723-01 $5,000 metzger, monika ST. JUDE CHILDREN'S RESEARCH HOSPITAL
3
A bifunctional nanomedicine for both specific imaging and targeting therapy of an 5R01CA151955-02 $309,964 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE
4
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $213,606 Rothman, Nat DCEG (NCI)
5
A Fourth Outcome: DNA Damage and the Differentiation of B Cells 1R01CA156674-01 $314,884 TEITELL, MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES
6
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera 5R01CA139119-02 $260,852 Chaudhary, Preet UNIVERSITY OF SOUTHERN CALIFORNIA
7
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1 ZIA BC 011064 $243,917 Mock, Beverly CCR (NCI)
8
A multi-center international hospital-based case-control study of lymphoma in Asi ZIA CP010136-10512 $337,239 Lan, Qing DCEG (NCI)
9
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE 1U54CA155496-01 $1,814,496 COLDITZ, GRAHAM WASHINGTON UNIVERSITY
10
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma 1R43CA159843-01 $149,959 Balhorn, Rodney SHAL TECHNOLOGIES, INC.
11
A novel enzymatic activity of WSTF and its role in tumorigenesis 5R00CA131560-04 $241,530 Xiao, zhuo YALE UNIVERSITY
12
A Phase I trial combining fenretinide and safingol to target overproduction of di 1R21CA161889-01 $323,700 MAURER, BARRY TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
13
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma 1R01CA149445-01A1 $617,616 BIRMANN, BRENDA BRIGHAM AND WOMEN'S HOSPITAL
14
A Role for KSHV in the Pathogenesis of Malignancies ZIA SC 010356 $370,199 Tosato, Giovanna CCR (NCI)
15
Abramson Cancer Center Support Grant 2P30CA016520-35 $7,696,742 LERMAN, CARYN UNIVERSITY OF PENNSYLVANIA
16
Abramson Cancer Center Support Grant 3P30CA016520-35S1 $50,000 LERMAN, CARYN UNIVERSITY OF PENNSYLVANIA
17
Abrogating human CD59 activity for antibody-based cancer therapy 5R21CA141324-02 $214,562 Qin, Xuebin HARVARD UNIVERSITY (MEDICAL SCHOOL)
18
Academic Training in Medical Oncology 3T32CA009297-28S1 $66,919 RIBAS, ANTONI UNIVERSITY OF CALIFORNIA LOS ANGELES
19
Academic Training in Medical Oncology 5T32CA009297-28 $316,308 RIBAS, ANTONI UNIVERSITY OF CALIFORNIA LOS ANGELES
20
Activation of BCL-2 in Hematologic Malignancies 5R01CA056764-17 $281,785 BOXER, LINDA PALO ALTO INSTITUTE FOR RES & EDU, INC.
21
Activation of Proto-Oncogenes by Chromosomal Translocation ZIA SC 010378 $328,740 Aplan, Peter CCR (NCI)
22
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center 5U01CA096230-09 $731,978 MCGRATH, MICHAEL UNIVERSITY OF CALIFORNIA SAN FRANCISCO
23
AIDS Associated Lymphoproliferative Disorders 5R37CA037295-28 $390,425 DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES
24
AIDS Malignancy Clinical Trials Consortium (AMC) 3U01CA121947-04S1 $200,000 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
25
AIDS Malignancy Clinical Trials Consortium (AMC) 3U01CA121947-04S2 $450,000 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
26
AIDS Malignancy Clinical Trials Consortium (AMC) 3U01CA121947-04S3 $150,000 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
27
AIDS Malignancy Clinical Trials Consortium (AMC) 5U01CA121947-05 $5,189,968 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
28
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $58,058 Kochenderfer, James CCR (NCI)
29
Allotransplant for DOCK8 deficiency ZIA BC 011374 $157,995 Hickstein, Dennis CCR (NCI)
30
Altered cellular bioenergetics influences NKT cell mediated responses to Lymphoma 1R21CA162277-01 $195,750 Webb, Tonya UNIVERSITY OF MARYLAND BALTIMORE
31
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors 5R01CA122658-05 $361,253 KNOBF, M. Tish YALE UNIVERSITY
32
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression 5R01CA130752-04 $299,900 FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA
33
Analysis of the p53 in vivo using a unique mouse model 5R01CA100193-09 $334,263 EVAN, GERARD UNIVERSITY OF CALIFORNIA SAN FRANCISCO
34
Anatomic Pathology Residency Program ZIE BC 011384 $1,179,485 Oberholtzer, J. CCR (NCI)
35
Animal Model and Genotyping Core Support Facility ZIC BC 011047 $1,220,780 DuBois, Wendy CCR (NCI)
36
Anti-viral DC/NK interactions 5R01CA108609-08 $176,961 MUNZ, CHRISTIAN UNIVERSITY OF ZURICH
37
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies ZIA BC 010647 $388,021 Rader, Christoph CCR (NCI)
38
Antibody-based therapeutics and vaccines against AIDS ZIA BC 011155 $178,463 Dimitrov, Dimiter CCR (NCI)
39
Antibody-CpG conjugates for the treatment of B cell lymphoma 5R01CA149254-02 $309,964 Timmerman, John UNIVERSITY OF CALIFORNIA LOS ANGELES
40
Antibody-interferon fusion proteins for treatment of B-cell malignancies 1R01CA162964-01 $319,550 MORRISON, SHERIE UNIVERSITY OF CALIFORNIA LOS ANGELES
41
Antibody-mediated Gene Therapy for the Treatment of Cancer 5K01CA138559-03 $142,677 Daniels, Tracy UNIVERSITY OF CALIFORNIA LOS ANGELES
42
Approaches to discover and quantify apoptotic biomarkers for cancer treatment 1R01CA154802-01 $320,588 WELLS, JAMES UNIVERSITY OF CALIFORNIA SAN FRANCISCO
43
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-33S1 $139,575 Alberts, David UNIVERSITY OF ARIZONA
44
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-33S2 $75,000 Alberts, David UNIVERSITY OF ARIZONA
45
Arizona Cancer Center-Cancer Center Support Grant 5P30CA023074-33 $3,953,813 Alberts, David UNIVERSITY OF ARIZONA
46
ATBC Study ZIA CP010195-03031 $828,679 Albanes, Demetrius DCEG (NCI)
47
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011413 $116,117 Kochenderfer, James CCR (NCI)
48
B Cell Lymphoma Therapy 5R01CA121039-05 $236,918 CHOI, YONG OCHSNER CLINIC FOUNDATION
49
Basis for Lymphomagenesis in Akt2 Transgenic Mice 5R01CA077429-12 $419,987 TESTA, JOSEPH FOX CHASE CANCER CENTER
50
Bay Area Tumor Institute CCOP 5U10CA045461-22 $406,165 Feusner, James BAY AREA TUMOR INSTITUTE
Relevant funding data is only available when one cancer type or one research topic is selected.
Showing 1 - 50 of 689 results
Go to top